Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Change in Accured Expenses (2016 - 2025)

Ocugen (OCGN) has disclosed Change in Accured Expenses for 12 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 42.27% year-over-year to $1.2 million, compared with a TTM value of $3.3 million through Dec 2025, down 19.97%, and an annual FY2025 reading of $3.3 million, down 19.97% over the prior year.
  • Change in Accured Expenses was $1.2 million for Q4 2025 at Ocugen, down from $3.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.7 million in Q3 2022 and bottomed at -$5.0 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is $404500.0, with a median of $1.1 million recorded in 2021.
  • The sharpest move saw Change in Accured Expenses soared 21460.0% in 2021, then plummeted 3889.31% in 2023.
  • Year by year, Change in Accured Expenses stood at $573000.0 in 2021, then skyrocketed by 405.24% to $2.9 million in 2022, then tumbled by 167.05% to -$1.9 million in 2023, then surged by 207.62% to $2.1 million in 2024, then plummeted by 42.27% to $1.2 million in 2025.
  • Business Quant data shows Change in Accured Expenses for OCGN at $1.2 million in Q4 2025, $3.3 million in Q3 2025, and $2.1 million in Q2 2025.